Close
Help




JOURNAL

Ophthalmology and Eye Diseases

Tafluprost for the Reduction of Interocular Pressure in Open Angle Glaucoma and Ocular Hypertension

Submit a Paper


Ophthalmology and Eye Diseases 2011:3 13-19

Review

Published on 12 Jun 2011

DOI: 10.4137/OED.S4253


Further metadata provided in PDF



Sign up for email alerts to receive notifications of new articles published in Ophthalmology and Eye Diseases

Abstract

Tafluprost is an FP receptor antagonist that has been shown in clinical studies in Europe and Japan to be extremely useful in treating elevated intraocular pressure and glaucoma. The drug is well tolerated and appears to be at least equal in effectiveness and perhaps superior to other protanoids for routine use comparison to be superior to other treatments for the elevated IOP as the side effects and other related symptomology appear to be less, while maintaining a level of pressure control for prolonged periods.



Downloads

PDF  (456.18 KB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)

XML

PMC HTML


Sharing


What Your Colleagues Say About Ophthalmology and Eye Diseases
I have to say this was one of my most pleasant and friendly experiences as a peer reviewer. The clear and straight-forward requirements of Ophthalmology and Eye Diseases is a breath of fresh air in peer reviewing.
Dr Lampros Panagis (SUNY Downstate Medical Center, Brooklyn, NY, USA )
More Testimonials

Quick Links


New article and journal news notification services
Email Alerts RSS Feeds
Facebook Google+ Twitter
Pinterest Tumblr YouTube